Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

5.09
+0.17003.46%
Post-market: 5.110.0200+0.39%19:04 EDT
Volume:1.69M
Turnover:8.58M
Market Cap:469.18M
PE:-4.55
High:5.17
Open:4.93
Low:4.93
Close:4.92
Loading ...

Myriad Genetics initiated with a Buy at Craig-Hallum

TIPRANKS
·
12 Feb

MYGN Stock Might Rise on Collaboration With CancerCARE

Zacks
·
11 Feb

Myriad Genetics management to meet with BTIG

TIPRANKS
·
07 Feb

Myriad Genetics and Cancercare for Life Announce Agreement to Advance Access to Myrisk With Riskscore Hereditary Cancer Test

THOMSON REUTERS
·
06 Feb

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

GlobeNewswire
·
06 Feb

Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay

MT Newswires Live
·
06 Feb

Myriad Genetics issued two new patents from USPTO

TIPRANKS
·
06 Feb

BRIEF-Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay

Reuters
·
06 Feb

Myriad Genetics Announces Two New Patents Granted for Its Molecular Residual Disease (Mrd) Assay

THOMSON REUTERS
·
06 Feb

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

GlobeNewswire
·
06 Feb

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and Myrisk Hereditary Cancer Tests Through Bxlink Integration

THOMSON REUTERS
·
05 Feb

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

GlobeNewswire
·
05 Feb

Biote Announces CEO Retirement and Succession Plan

Business Wire
·
31 Jan

Myriad Genetics Is Maintained at Neutral by Piper Sandler

Dow Jones
·
30 Jan

Myriad Genetics price target lowered to $14 from $24 at Piper Sandler

TIPRANKS
·
30 Jan

Myriad Genetics unveils resesrch at SMFM on cfDNA

TIPRANKS
·
29 Jan

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

GlobeNewswire
·
29 Jan

Myriad Genetics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
28 Jan

Why Is Larry Robbins Bullish on Myriad Genetics, Inc. (MYGN) Now?

Insider Monkey
·
25 Jan

MYGN Stock Gains Following the Launch of Know More Sooner

Zacks
·
24 Jan